|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Net premiums earned | |||||
| Net investment income | |||||
| Other insurance related income | |||||
| Allowance for expected credit losses | |||||
| Impairment losses | |||||
| Net investment gains (losses): | |||||
| Increase in allowance for expected credit losses | |||||
| Impairment losses | |||||
| Other realized and unrealized investment gains (losses) | |||||
| Total net investment gains (losses) | |||||
| Total revenues | |||||
| Expenses | |||||
| Net losses and loss expenses | |||||
| Acquisition costs | |||||
| General and administrative expenses | |||||
| Foreign exchange losses (gains) | |||||
| Interest expense and financing costs | |||||
| Reorganization expenses | |||||
| Amortization of value of business acquired | |||||
| Amortization of intangible assets | |||||
| Total expenses | |||||
| Income before income taxes and interest in income of equity method investments | |||||
| Income tax (expense) benefit | |||||
| Interest in income of equity method investments | |||||
| Net income | |||||
| Preferred share dividends | |||||
| Net income available to common shareholders | |||||
| Per share data | |||||
| Earnings per common share: | |||||
| Earnings per common share (in dollars per share) | |||||
| Earnings per diluted common share (in dollars per share) | |||||
| Weighted average common shares outstanding (in shares) | |||||
| Weighted average diluted common shares outstanding (in shares) | |||||
Loading...